Stock listing

OTC:RNVA Rennova Health, Inc. Stock

Follow Rennova Health, Inc. into a list and get an email when it puts out news.

Rennova Health, Inc. logo
Ticker
OTC:RNVA
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
OTC
Currency
USD

Latest news

All Rennova Health, Inc. news

Rennova Health, Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
31 in all · newest Sep 9, 2020 · oldest 2017
Decks
19 decks · latest Jul 11, 2017

Team and board

Officers

OfficerRole
Seamus LaganPresident, Chief Executive Officer, and Director

Board

DirectorRole
Gary L. BlumDirector
Seamus LaganPresident, Chief Executive Officer, and Director
Trevor LangleyDirector

Events

QuarterResults
Quarter to Sep 30, 2024Nov 18, 2024
Quarter to Jun 30, 2024Aug 13, 2024
Quarter to Mar 31, 2024May 13, 2024
Q4 2023Feb 28, 2024
Q3 2023Nov 14, 2023
Q2 2023Aug 15, 2023
Q1 2023Apr 17, 2023
Q4 2022Mar 1, 2023
Q3 2022Nov 14, 2022
Q2 2022Aug 15, 2022
All 16 quarters
QuarterResults
Q1 2022May 16, 2022
Q4 2021Mar 2, 2022
Q3 2021Nov 15, 2021
Q2 2021Aug 17, 2021
Q1 2021May 17, 2021
Q4 2020Mar 3, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (July 2017)Investor deck21 slidesJul 11, 2017
Investor Presentation (July 2017)Investor deck21 slidesJuly 2017
Investor Presentation (January 2017)Investor deck20 slidesJanuary 2017
IPO Roadshow (December 2016)IPO roadshow22 slidesDec 9, 2016
Investor Presentation (September 2016)Investor deck24 slidesSep 27, 2016
Investor Presentation (September 2016)Investor deck24 slidesSeptember 2016
Investor Presentation (July 2016)Investor deck25 slidesJul 11, 2016
Investor Presentation (June 2016)Investor deck22 slidesJune 2016
Investor Presentation (May 2016)Investor deck23 slidesMay 3, 2016
Investor Presentation (January 2016)Investor deck15 slidesJanuary 2016
All 19 decks
DeckKindSlidesDate
IPO Roadshow (December 2015)IPO roadshow17 slidesDec 7, 2015
Investor Presentation (December 2015)Investor deck17 slidesDec 1, 2015
CollabRx — Merger or Acquisition (September 2015)Merger or acquisition27 slidesSep 23, 2015
CollabRx — Merger or Acquisition (July 2015)Merger or acquisition26 slidesJul 29, 2015
CollabRx — IPO Roadshow (February 2015)IPO roadshow27 slidesFeb 17, 2015
CollabRx — IPO Roadshow (November 2014)IPO roadshow22 slidesNov 18, 2014
CollabRx — IPO Roadshow (June 2014)IPO roadshow24 slidesJun 18, 2014
CollabRx — Investor Presentation (January 2013)Investor deck20 slidesJan 9, 2013
Tegal — Merger or Acquisition (September 2008)Merger or acquisition13 slidesSep 2, 2008

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue18.7M18.7M13.0M3.22M7.20M16.0M14.5M3.09M3.34M18.4M
Cost of revenue7.57M7.57M6.77M5.29M11.8M15.6M11.5M2.66M3.66M12.5M
Gross profit11.1M11.1M6.27M-2.07M-4.58M449.0K3.04M424.1K-321.9K5.89M
Research and development2.07M415.5K
Selling, general and administrative9.44M9.44M7.22M7.51M11.7M16.7M14.8M15.8M23.7M27.8M
Operating income1.37M1.37M-1.41M-12.5M-17.2M-15.7M-13.1M-16.1M-21.5M-25.3M
Depreciation and amortization310.5K310.5K469.4K643.6K701.0K795.2K1.26M1.72M2.42M2.75M
EBITDA1.68M1.68M-940.2K-11.9M-16.5M-14.9M-11.8M-14.4M-19.0M-22.6M
Interest expense1.45M1.45M2.26M3.19M9.84M21.7M21.5M21.4M6.31M2.69M
Income before tax-314.0K-314.0K-3.04M-5.09M-19.0M-46.6M-12.8M-49.9M-23.4M-45.0M
Income tax239.8K312.8K179.5K-1.31M766.1K766.1K1.02M-778.8K-9.03M
Net income-7.73M-7.73M-3.29M5.61M-18.3M-48.0M-14.0M-55.2M-32.6M-36.0M
Earnings per share, basic-0.00-0.00-0.0010.22-6,113.26-47,937.95-1,090.72-452.13-1,302.66

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents49.0K49.0K499.5K724.5K25.4K16.9K6.87K-2.08M78.0K8.83M
Receivables6.65M3.09M5.41M3.59M1.92M4.21M4.44M2.91M2.93M12.0M
Inventory198.2K198.2K242.6K280.5K445.4K614.3K453.4K236.9K1
Current assets6.94M6.94M6.36M4.72M2.72M5.35M5.12M3.39M3.22M22.0M
Property, plant and equipment5.45M7.81M8.32M8.53M2.70M2.80M7.15M
Total assets20.3M20.3M20.6M19.6M12.3M14.7M14.2M6.29M6.48M29.4M
Accounts payable12.4M12.4M11.2M12.1M14.3M13.1M8.16M4.19M3.35M4.36M
Current liabilities42.5M42.5M49.3M46.4M59.2M83.4M44.4M24.9M19.6M17.8M
Long-term debt8.22M1.20M3.75M02.90M
Total debt11.8M15.1M16.1M22.0M50.2M15.5M12.9M12.0M
Total liabilities57.1M57.1M49.7M46.9M61.3M83.6M53.4M41.1M21.4M30.6M
Shareholders' equity-36.8M-36.8M-29.1M-27.3M-49.0M-68.9M-39.2M-34.8M-14.9M-1.19M
Shares outstanding32.8B40.6B9.99B548.4K3.00K1.00K12.9K372.1K27.6K

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations3.39M3.39M-218.3K-8.91M-16.9M-13.5M-7.68M-17.7M-19.9M-12.6M
Capital spending-350.9K-350.9K-35.2K-35.2K-370.9K-125-213.1K-1.42M-18.1K-456.3K
Free cash flow3.04M3.04M-253.6K-8.91M-17.3M-13.5M-7.89M-19.1M-19.9M-13.0M
Cash from investing-1.53M-905.2K-374.5K-288.9K-658.7K662.6K-492.5K63.3K4.28M
Cash from financing-2.31M-2.31M898.5K9.61M17.2M14.2M7.02M18.1M11.0M14.7M
Dividends paid-9.00M-24.5M-16.3M-441.3K
Share buybacks0-9-244-684-100-47-6.67K-8.35M9.74M
Change in cash-450.5K-450.5K-225.1K699.2K8.42K10.1K6.87K-70.2K-8.76M6.43M

Open Financials

Cap table

Built by 6ix from Rennova Health, Inc.’s releases

Common shares
43,051,322,257
Fully diluted
43,051,322,257

Fully diluted

LineShares
Common shares43,051,322,257

Share count over time

CountShares
Nov 22, 202643,051,322,257

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael H Pollack
Other companies: TraqIQ Inc (Interim CFO · Sep 22, 2021 – Sep 22, 2021 · Past); Vivos Inc (INTERIM CFO · Dec 8, 2018 – Mar 24, 2023 · Past); Dominari Holdings Inc. (Interim CFO · Oct 11, 2013 – Oct 11, 2013 · Past)
Interim CFO · May 23, 2017 – May 23, 2017 · Past
Marlene McLennan
Other companies: Aspira Women's Health Inc. (Interim Chief Financial Office · Dec 1, 2022 – Dec 1, 2022 · Past)
Chief Financial Officer · Jul 1, 2018 – Jul 1, 2018 · Past
Seamus Lagan
Other companies: FOXO Technologies Inc. (Chief Executive Officer and Interim Chief Financial Officer · Since at least Sep 10, 2024)
President, Chief Executive Officer, and Director · Since at least Nov 2, 2015
Trevor Langley
Other companies: FOXO Technologies Inc. (Chairman of the Board · Since at least Sep 10, 2024)
Director · Since at least Apr 9, 2017
Benjamin FrankDirector · Nov 2, 2015 – Jul 17, 2016 · Past
Gary L. BlumDirector · Since at least Nov 5, 2026
Jason AdamsChief Financial Officer · Nov 2, 2015 – Jul 17, 2016 · Past
Kamran AjamiDirector · Apr 9, 2017 – Mar 6, 2018 · Past
Michael Louis GoldbergDirector · May 2, 2016 – Jul 17, 2016 · Past
Samuel R Mitchell JrChief Operating Officer · Nov 2, 2015 – Nov 2, 2015 · Past
All 11 people
PersonSeat
Smruti J VidwansChief Science Officer · Nov 2, 2015 – Nov 2, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Rennova Health, Inc.